Click any of the icons below to view our current NDN clinical trial research studies
EXENATIDE – PD3
Phase 3 Trial of Exenatide for Parkinson’s disease
EVOKE/ EVOKE+
Investigating Semaglutide in People with Early Alzheimer’s Disease
CHIEF-PD
CHolinesterase Inhibitors
to PrEvent Falls in Parkinson’s disease
Probiotic
Investigating the effects of B. Subtilis Bacteria on the microbiome in Parkinson’s Disease
TOP-HAT
Trial of Ondansetron as a Parkinson’s Hallucinations Treatment
Coming soon…
Keep coming back to the website to see our upcoming studies
